| Filed On | Filing |
|---|---|
| 10 Sep 2024 |
8-K/A: Material Modification to Rights of Security Holders; Departure/Election of Directors or Officers; Compensation +2 more
Allarity Therapeutics, Inc., a corporation organized and existing under and by virtue of the General Corporation Law of the State of Delaware. |
| 24 May 2024 |
8-K/A: Results of Operations and Financial Condition; Other Events
On May 14, 2024, the Company issued a press release announcing its financial results for its fiscal quarter ended March 31, 2024 (the “Press Release”). A copy of the Press Release is furnished as Exhibit 99.1 to this Current Report on Fo... |
| 24 Aug 2022 |
8-K/A: Changes in Registrant's Certifying Accountant
We have read the statements made by Allarity Therapeutics, Inc. under Item 4.01 of its Form 8-K (“Item 4.01”) dated August 8, 2022, and have the following comments: |
| 19 May 2022 | 8-K/A: Results of Operations and Financial Condition; Regulation FD Disclosure |
| 01 Apr 2022 | 8-K/A: Non-Reliance on Previously Issued Financial Statements |
Loading...
